| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.319 | 38.315 | - | 13.343 | 69.303 | 114.145 | 50.880 | 41.986 | 82.253 | 151.456 |
| Total Income - EUR | 51.802 | 39.820 | - | 15.255 | 107.532 | 151.666 | 78.350 | 120.952 | 172.939 | 320.481 |
| Total Expenses - EUR | 67.676 | 39.606 | - | 24.730 | 142.958 | 149.929 | 76.255 | 116.834 | 169.245 | 314.304 |
| Gross Profit/Loss - EUR | -15.874 | 214 | - | -9.474 | -35.426 | 1.737 | 2.095 | 4.118 | 3.695 | 6.177 |
| Net Profit/Loss - EUR | -17.402 | -935 | - | -9.894 | -36.792 | 553 | 1.153 | 3.694 | 2.535 | 975 |
| Employees | 1 | 1 | - | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Cri Genetics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.553 | 25.409 | - | 29.423 | 31.258 | 63.658 | 56.394 | 47.232 | 99.058 | 134.772 |
| Current Assets | 27.437 | 30.776 | - | 73.246 | 69.107 | 79.956 | 83.516 | 138.530 | 110.275 | 169.047 |
| Inventories | 6.633 | 12.497 | - | 44.787 | 43.427 | 51.408 | 72.526 | 128.584 | 97.844 | 137.142 |
| Receivables | 18.997 | 16.167 | - | 18.114 | 22.493 | 27.675 | 5.016 | 7.685 | 11.536 | 31.049 |
| Cash | 1.807 | 2.112 | - | 10.344 | 3.187 | 874 | 5.975 | 2.261 | 895 | 857 |
| Shareholders Funds | -16.650 | -17.415 | - | -23.962 | -67.674 | -73.960 | -71.167 | -67.693 | -69.352 | -67.989 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 48.640 | 73.600 | - | 126.631 | 168.039 | 217.598 | 211.077 | 253.464 | 278.713 | 371.808 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "162 - 162" | |||||||||
| CAEN Financial Year |
162
|
|||||||||
Comments - Cri Genetics Srl